Abstract

Genetic correlations and an increased incidence of psychiatric disorders in inflammatory-bowel disease have been reported, but shared molecular mechanisms are unknown. We performed cross-tissue and multiple-gene conditioned transcriptome-wide association studies for 23 tissues of the gut-brain-axis using genome-wide association studies data sets (total 180,592 patients) for Crohn’s disease, ulcerative colitis, primary sclerosing cholangitis, schizophrenia, bipolar disorder, major depressive disorder and attention-deficit/hyperactivity disorder. We identified NR5A2, SATB2, and PPP3CA (encoding a target for calcineurin inhibitors in refractory ulcerative colitis) as shared susceptibility genes with transcriptome-wide significance both for Crohn’s disease, ulcerative colitis and schizophrenia, largely explaining fine-mapped association signals at nearby genome-wide association study susceptibility loci. Analysis of bulk and single-cell RNA-sequencing data showed that PPP3CA expression was strongest in neurons and in enteroendocrine and Paneth-like cells of the ileum, colon, and rectum, indicating a possible link to the gut-brain-axis. PPP3CA together with three further suggestive loci can be linked to calcineurin-related signaling pathways such as NFAT activation or Wnt.

Florian Uellendahl-Werth et al. conduct cross-tissue transcriptome-wide association studies to explore genetic mechanisms shared across immune-related and psychiatric traits. Their results identify several genes (including PPP3CA) that could mediate the interplay between psychiatric and inflammatory disease.

Details

Title
Cross-tissue transcriptome-wide association studies identify susceptibility genes shared between schizophrenia and inflammatory bowel disease
Author
Uellendahl-Werth Florian 1   VIAFID ORCID Logo  ; Maj, Carlo 2   VIAFID ORCID Logo  ; Borisov Oleg 2 ; Juzenas Simonas 3   VIAFID ORCID Logo  ; Wacker, Eike Matthias 1   VIAFID ORCID Logo  ; Jørgensen, Isabella Friis 4   VIAFID ORCID Logo  ; Steiert, Tim Alexander 1 ; Bej Saptarshi 5 ; Krawitz, Peter 2   VIAFID ORCID Logo  ; Hoffmann, Per 6 ; Schramm Christoph 7 ; Wolkenhauer Olaf 8   VIAFID ORCID Logo  ; Banasik Karina 4   VIAFID ORCID Logo  ; Brunak Søren 4   VIAFID ORCID Logo  ; Schreiber, Stefan 9 ; Karlsen Tom Hemming 10   VIAFID ORCID Logo  ; Degenhardt Franziska 11 ; Nöthen Markus 6   VIAFID ORCID Logo  ; Franke, Andre 1 ; Folseraas Trine 10 ; Ellinghaus, David 12   VIAFID ORCID Logo 

 Christian-Albrechts-University of Kiel, Institute of Clinical Molecular Biology, Kiel, Germany (GRID:grid.9764.c) (ISNI:0000 0001 2153 9986) 
 University of Bonn, Institute for Genomic Statistics and Bioinformatics, Bonn, Germany (GRID:grid.10388.32) (ISNI:0000 0001 2240 3300) 
 Christian-Albrechts-University of Kiel, Institute of Clinical Molecular Biology, Kiel, Germany (GRID:grid.9764.c) (ISNI:0000 0001 2153 9986); Vilnius University, Institute of Biotechnology, Life Science Centre, Vilnius, Lithuania (GRID:grid.6441.7) (ISNI:0000 0001 2243 2806) 
 University of Copenhagen, Novo Nordisk Foundation Center for Protein Research, Disease Systems Biology, Faculty of Health and Medical Sciences, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X) 
 University of Rostock, Department of Systems Biology & Bioinformatics, Rostock, Germany (GRID:grid.10493.3f) (ISNI:0000000121858338) 
 University of Bonn, Department of Genomics, Life & Brain Center, Bonn, Germany (GRID:grid.10388.32) (ISNI:0000 0001 2240 3300); University of Bonn & University Hospital Bonn, Institute of Human Genetics, School of Medicine, Bonn, Germany (GRID:grid.10388.32) (ISNI:0000 0001 2240 3300) 
 University Medical Center Hamburg-Eppendorf, First Department of Internal Medicine, Hamburg, Germany (GRID:grid.13648.38) (ISNI:0000 0001 2180 3484) 
 University of Rostock, Department of Systems Biology & Bioinformatics, Rostock, Germany (GRID:grid.10493.3f) (ISNI:0000000121858338); Wallenberg Research Centre at Stellenbosch University, Stellenbosch Institute of Advanced Study (STIAS), Stellenbosch, South Africa (GRID:grid.11956.3a) (ISNI:0000 0001 2214 904X); Technical University Munich, Leibniz Institute for Food Systems Biology, Freising, Germany (GRID:grid.6936.a) (ISNI:0000000123222966) 
 Christian-Albrechts-University of Kiel, Institute of Clinical Molecular Biology, Kiel, Germany (GRID:grid.9764.c) (ISNI:0000 0001 2153 9986); University Hospital Schleswig-Holstein, First Medical Department, Kiel, Germany (GRID:grid.412468.d) (ISNI:0000 0004 0646 2097) 
10  Oslo University Hospital Rikshospitalet and University of Oslo, Research Institute for Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo, Norway (GRID:grid.55325.34) (ISNI:0000 0004 0389 8485) 
11  University Hospital Essen, University of Duisburg-Essen, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Duisburg, Germany (GRID:grid.5718.b) (ISNI:0000 0001 2187 5445) 
12  Christian-Albrechts-University of Kiel, Institute of Clinical Molecular Biology, Kiel, Germany (GRID:grid.9764.c) (ISNI:0000 0001 2153 9986); University of Copenhagen, Novo Nordisk Foundation Center for Protein Research, Disease Systems Biology, Faculty of Health and Medical Sciences, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
23993642
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2621430475
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.